Valeur pronostique et prédictive de la graisse viscérale en cancérologie digestive (notice n° 663179)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03222cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121193242.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wilson, Olivia |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Valeur pronostique et prédictive de la graisse viscérale en cancérologie digestive |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2021.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 74 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La graisse viscérale est la graisse contenue dans la cavité péritonéale. Son accumulation engendre des altérations métaboliques et des maladies telles que le syndrome métabolique, l’infarctus du myocarde ou encore le cancer. Ces manifestations sont liées aux mécanismes physiopathologiques mis en jeu via des hormones et des cytokines favorisant l’angiogenèse, la prolifération cellulaire et inhibant l’apoptose. Parmi elles, on peut citer la leptine, le TNFα, la PAI-1 et l’IL-6. Le scanner abdominal est l’examen de référence pour déterminer la surface de graisse viscérale. Une coupe unique au niveau de l’ombilic ou de L3 permet la réalisation de cette mesure. En cancérologie digestive, peu d’études ont évalué la valeur pronostique de la graisse viscérale. La plupart d’entre elles vont dans le sens d’un rôle péjoratif de l’obésité viscérale sur la survie et d’une association à un risque plus élevé de complication post-opératoire. L’augmentation de la prévalence de l’obésité et les complications qui en découlent doit nous encourager à porter une plus grande attention à ce facteur pronostique émergeant et prédictif des effets des traitements. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Visceral fat is the fat contained in the peritoneal cavity. Visceral fat accumulation causes metabolic disorders and diseases such as metabolic syndrome, myocardial infarction or cancer. These manifestations are related to physiopathological mechanisms involved via hormones and cytokines promoting angiogenesis, cell proliferation and inhibiting apoptosis. Leptin, TNFα, PAI-1 and IL-6 are part of those hormones and cytokines. Abdominal CT is the gold standard to determine visceral fat area. One cross-sectional scan obtained at the umbilicus or L3 level is sufficient. In gastrointestinal oncology, few studies evaluate the prognostic value of visceral fat. Most of them describe a pejorative role of visceral obesity. The increase of obesity prevalence and the resulting complications should prompt us to pay more attention to this emerging prognostic and predictive factor. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | graisse viscérale |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | valeur pronostique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | carcinogenèse |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancérologie digestive |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | angiogenèse |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | carcinogenesis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | visceral fat |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | angiogenesis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prognostic value |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | gastrointestinal cancerology |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berthon, Geoffrey |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Regnault, David |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cazeneuve, Nicolas |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ouaissi, Mehdi |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lecomte, Thierry |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 28 | 4 | 2021-04-01 | p. 478-484 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2021-4-page-478?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2021-4-page-478?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux